Key result
Novel therapies targeting inflammation, fibrosis, and cell death show potential against myocardial remodeling in HF.
Why the study?
Classical heart failure therapy treats predisposing factors and secondary neurohumoral activation, while an emerging view proposes directly intervening on pathological structural myocardial remodeling. Increasing knowledge of remodeling mechanisms enables the exploration of novel therapeutic targets to prevent or reverse inflammation, collagen matrix alterations, and cardiomyocyte death.
This review examines experimental and pilot clinical insights into novel therapeutic targets aimed at preventing or reversing myocardial inflammation, collagen matrix alterations, and cardiomyocyte death in heart failure.
Answers are grounded in this paper and cite their sources.
Targets for myocardial remodeling require validation; leaves open clinical translation pending prospective trials.
Classical therapy of heart failure is based on treatment of its pre-disposing/triggering factors and of the neurohumoral activation secondary to the deterioration of cardiac function. A new view is emerging that proposes the direct intervention on the pathological structural remodeling of the myocardium as part of heart failure therapy. In fact, in conditions of chronic injury, the cardiomyocytic and the noncardiomyocytic components of the myocardium undergo a series of structural lesions (i.e., cardiomyocyte growth and death, inflammation, alterations of collagen matrix, and microvascular rarefaction) that are governed by a complex interplay of mechanisms. Our increasing knowledge of the role of these mechanisms in remodeling enables us not only to better understand how our more successful therapies work but also to explore novel therapies for the future. In this paper, we will examine recent insights from experimental and pilot clinical studies that have provided new targets for interventions to prevent or reverse inflammation, alterations of collagen matrix, and cardiomyocyte death.
No takes yet. Share an insight, caveat, or question.
González et al. (2011) conducted a review in Heart failure and myocardial structural remodeling. Interventions targeting pathological structural remodeling of the myocardium (inflammation, collagen matrix alterations, and cardiomyocyte death) was evaluated. Novel interventions targeting inflammation, collagen matrix alterations, and cardiomyocyte death are reviewed as potential strategies to treat structural myocardial remodeling in heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: